| Business Summary | | Ascent
Pediatrics,
Inc.
markets
products
to
the
pediatric
market.
The
Company's
Orapred
(prednisolone
sodium
phosphate
oral
solution)
syrup
is
a
prescription
liquid
steroid
for
the
treatment
of
inflammation
associated
with
a
variety
of
diseases,
principally
those
of
the
respiratory
system,
such
as
asthma
and
bronchitis.
The
Company's
Primsol
(trimethoprim
HCl
oral
solution)
is
a
prescription
drug
for
the
treatment
of
middle
ear
infections
in
children.
The
Company's
Pediamist
nasal
saline
spray
is
an
over-the-counter
product
to
relieve
nasal
dryness
associated
with
low
humidity.
The
Company's
Feverall
line
of
over-the-counter
acetaminophen
rectal
suppositories
treats
pain
and
fever.
The
Feverall
product
line
consists
of
four
strengths,
80mg,
120mg,
325mg
and
650mg. | More
from
Market Guide: Expanded
Business Description |
| Financial Summary | | ASCTP
is
a
drug
development
and
marketing
company
focused
exclusively
on
the
pediatric
market.
The
Company
is
developing
a
broad
product
line
of
proprietary
products
based
on
approved
compounds.
For
the
three
months
ended
3/31/01,
revenues
fell
8%
to
$1
million.
Net
loss
totaled
$10.3
million,
up
from
$3.6
million.
Results
reflect
the
termination
of
Omnicef
and
Pediotic
agreements,
and
an
increase
in
interest
expense
due
to
the
amortization
of
$5
million
of
the
Sr.
H
redemption
price. | More
from
Market Guide: Significant
Developments |
| Officers | | | FY2000 Pay | |
| Emmett Clemente, Ph.D., 62 Chairman,
Pres, Treasurer | $260K | Robert Baldini, 70 Vice
Chairman | -- | Dollar amounts are as of 31-Dec-2000 and compensation values are for the fiscal year ending on that date; "Pay" is salary, bonuses, etc.. |
| More
from
Market Guide on Officers & Directors: Expanded
List, Bios,
Compensation,
Options
|
|